a45 Pill - yellow capsule/oblong, 14mm
Generic Name: upadacitinib
Pill with imprint a45 is Yellow, Capsule/Oblong and has been identified as Rinvoq 45 mg. It is supplied by AbbVie Inc.
Rinvoq is used in the treatment of Crohn's Disease; Ankylosing Spondylitis; Atopic Dermatitis; Non-Radiographic Axial Spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class antirheumatics. Rinvoq 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for a45
Rinvoq
- Generic Name
- upadacitinib
- Imprint
- a45
- Strength
- 45 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-1043
Related images for "a45"
More about Rinvoq (upadacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (225)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.